Drug Type Peptide drug conjugates |
Synonyms- |
Target |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization ResoTher Pharma ASStartup |
Active Organization ResoTher Pharma ASStartup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Digestive System Disorders | Discovery | - | ResoTher Pharma ASStartup | 24 Feb 2022 |
Functional disorder | Discovery | - | ResoTher Pharma ASStartup | 24 Feb 2022 |
Immune System Diseases | Discovery | - | ResoTher Pharma ASStartup | 24 Feb 2022 |
Inflammation | Discovery | - | ResoTher Pharma ASStartup | 24 Feb 2022 |
Nervous System Diseases | Discovery | - | ResoTher Pharma ASStartup | 24 Feb 2022 |
Plaque, Atherosclerotic | Discovery | - | ResoTher Pharma ASStartup | 24 Feb 2022 |
Skin and Musculoskeletal Diseases | Discovery | - | ResoTher Pharma ASStartup | 24 Feb 2022 |
Urogenital Diseases | Discovery | - | ResoTher Pharma ASStartup | 24 Feb 2022 |